HomeBiosimilar Antibodies

Biosimilar Antibodies

Cat.No. Product Name Information Isotype
A2669 Lusvertikimab (Anti-IL-7Ra / CD127) Lusvertikimab (Anti-IL-7Ra / CD127) is a humanized monoclonal antibody targeting IL7R. It has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research. MW :145.64 KD. Human IgG4SP
A2925 Anti-GPR64 / ADGRG2 Anti-GPR64 / ADGRG2 is a monoclonal antibody (mAb) against G protein-coupled receptor 64 isoform 4 (anti-GPR64) with potential anti-tumour activity. MW: 146.1. Human IgG4SP
A2670 Anti-CXCL8 / IL-8 (HuMax-IL8) Anti-CXCL8 / IL-8 (HuMax-IL8) is a monoclonal antibody targeting CXCL8. It has strong antitumor effect. MW :144.94 KD. Human IgG1
A2926 Lonigutamab (Anti-IGF1R / CD221) Lonigutamab (hz208F2-4) is a humanized monoclonal antibody against the insulin-like growth factor-1 receptor (IGF-1R) with the potential to treat thyroid eye disease (TED). MW: 146.26 KD. Human IgG1
A2671 Anti-Lewis Y (MB 311) Anti-Lewis Y (MB 311) is a fully humanized monoclonal antibody recognizing the tumor-associated antigen Lewis Y. It represents an attractive target for cancer immunotherapy and can be used in treatment of breast cancer. MW 146.38 KD. Human IgG1
A2927 Losatuxizumab (Anti-ERBB1 / EGFR / HER1) Losatuxizumab (ABT-806) is a human monoclonal antibody against EGFR with anti-tumour activity. MW: 144.8 KD. Human IgG1
A2672 Anti-MAGEA3 Anti-MAGEA3 is an antibody that targets MAGE-A. It can be used in the treatment of metastatic cancer treatment. MW :145.56 KD. Human IgG1
A2928 Anti-Hepcidin / HAMP (anti_Hepsin) Anti-Hepcidin / HAMP is a monoclonal antibody (mAb) that neutralizing hepcidin and results in transferrin-mediated iron transport. MW: 142.68. Human IgG1
A2673 Anetumab (Anti-Mesothelin) Anetumab (Anti-Mesothelin) is an antibody targeting mesothelin (MSLN). It can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC) and can be used for the research of malignant tumor. MW :143.8 KD. Human IgG1
A2929 Anti-KID3 Anti-KID3 is a monoclonal antibody (MAb) directed against KID3, a carbohydrate epitope found in the colon and several forms of cancer. MW: 147.04 KD. Human IgG1
A2674 Oregovomab (Anti-MUC16) Oregovomab (Anti-MUC16) is a humanized monoclonal antibody that targets MUC16. It can be used in treatment of ovarian, pancreatic, breast, and lung cancers. MW 150 KD. Human IgG1
A2930 Anti-HGF / SF (TAK-701) Anti-HGF / SF (TAK-701) is a humanized monoclonal antibody directed against human hepatocyte growth factor (HGF) with potential antineoplastic activity. It reverses gefitinib resistance in non-small-cell lung cancer. MW: 145.04 KD. Human IgG1
A2675 Sofituzumab (Anti-MUC16) Sofituzumab (Anti-MUC16) is a humanized recombinant V-kappa antibody targeting MUC16. It can be used for the research of ovarian cancer. MW 144.7 KD. Human IgG1
A2676 Landogrozumab (Anti-GDF8 / Myostatin) Landogrozumab (Anti-GDF8 / Myostatin) is an humanized monoclonal antibody targeting myostatin. It effectively improves muscle volume, hand grip strength and function and can be used for the research of muscle wasting disease. MW :150 KD. Human IgG4SP
A2932 Anti-HGFR / c-Met (SAIT301) Anti-HGFR / c-Met (SAIT301) is a humanized monoclonal antibody targeting the alpha chain of the extracellular domain of the human hepatocyte growth factor receptor (HGFR or c-Met) with potential antineoplastic activity. MW: 146.0 KD. Human IgG1
A2677 Trevogrumab (Anti-GDF8 / Myostatin) Trevogrumab (Anti-GDF8 / Myostatin) is a monoclonal antibody targeting GDF8. It is used in studies of sarcopenia, including wasting atrophy, chronic diseases, and changes in food and nutritional intake. MW :150 KD. Human IgG4SP
A2933 Anti-Amyloid Beta (Merck anti-Amyloid beta 19.3) Anti-Amyloid Beta (Merck anti-Amyloid beta 19.3) is a human monoclonal antibody targeting beta-amyloid with the potential to treat Alzheimer’s disease. MW: 145.22 KD. Human IgG1
A2678 Fulranumab (Anti-NGF / bNGF) Fulranumab (Anti-NGF / bNGF) is a human IgG2 monoclonal antibody targeting nerve growth factor (NGF). It can be used for the research of pain. MW :145.37 KD. Human IgG2SA
A2679 Tanezumab (Anti-NGF / bNGF) Tanezumab (Anti-NGF / bNGF) is a human IgG2 monoclonal antibody targeting nerve growth factor (NGF). It can be used in studies of acute and chronic pain such as osteoarthritis, knee and neuralgia, as well as post-herpetic neuralgia. MW :150 KD. Human IgG1
A2935 Mirzotamab (Anti-B7-H3 / CD276) Mirzotamab (Anti-B7-H3 / CD276) is a human IgG1κ monoclonal antibody targeting CD276/B7-H3. Mirzotamab is used to produce Mirzotamab clezutoclax antibody drug conjugate (ADC). MW: 144.86 KD. Human IgG1